Renee Greaves completed her post-doctoral training in Tallahasee, FL in the area of general practice medicine with a focus in HIV. She currently practices as the Pharmacy Operations Supervisor at Broward General Medical Center in Ft. Lauderdale, FL with a specialty in infectious diseases and a subspecialty in critical care medicine. During the past two years, she has successfully created and maintained an Inpatient HIV Stewardship Program, spearheaded cardiac research for both inpatient and outpatient clinical trials, and serves as the PGY1 Residency Program Coordinator. Prior to this, she served as a Clinical Assistant Professor at Rutgers University School of Pharmacy and the Clinical Pharmacy Coordinator at Hunterdon Medical Center, where she implemented an antibiotic stewardship program which has received national recognition by the VHA.
SUNDAY FEBRUARY 19, 2012
NEW DRUG UPDATE
ACPE # 0043-9999-10-003-L01-P
1. Discuss the clinical indications for the new medications approved by the FDA.
2. Explain the various mechanisms of action for the medications discussed within this program.
3.Recognize the clinically relevant drug interactions for the medications.
4. Identify the most common adverse reactions for the new drug approvals.
5. Explain the approved dosing guidelines and recommended dosage adjustments for the medications reviewed.
Dr. Louie is an Associate Professor at the University of Southern California School of Pharmacy and the Keck School of Medicine, where he is concentrating his work on virally-linked diseases, which include human immunodeficiency virus (HIV), hepatitis B virus (HBV), and hepatitis C virus (HCV). In addition, he continues his efforts in drug discovery and development for the treatment of specific brain cancers and multiple myeloma.
ADVANCES IN HIV THERAPY
ACPE # 0043-9999-09-030-L01-P
Objectives:
1. Review and identify the mechansims of HIV infection and targets for pharmacotherapy.
2. Compare and contrast mechanisms of action of various antiretroviral agents.
3. Identify both clinical and laboratory values advocating the initiation of antiretroviral therapy.
4. Identify new agents in the fight against HIV and how they fit into the currently available agents.
5. Understand the antiviral effects associated with high active antiretroviral therapy (HAART).
6. Identify and manage possible drug-drug interactions between antiretroviral agents and other pharmacotherapeutic agents.
7. Understand and manage the various advers effects associated with antiretroviral agents.
Renee Greaves completed her post-doctoral training in Tallahasee, FL in the area of general practice medicine with a focus in HIV. She currently practices as the Pharmacy Operations Supervisor at Broward General Medical Center in Ft. Lauderdale, FL with a specialty in infectious diseases and a subspecialty in critical care medicine. During the past two years, she has successfully created and maintained an Inpatient HIV Stewardship Program, spearheaded cardiac research for both inpatient and outpatient clinical trials, and serves as the PGY1 Residency Program Coordinator. Prior to this, she served as a Clinical Assistant Professor at Rutgers University School of Pharmacy and the Clinical Pharmacy Coordinator at Hunterdon Medical Center, where she implemented an antibiotic stewardship program which has received national recognition by the VHA.
1. Discuss the clinical indications for the new medications approved by the FDA.
2. Explain the various mechanisms of action for the medications discussed within this program.
3.Recognize the clinically relevant drug interactions for the medications.
4. Identify the most common adverse reactions for the new drug approvals.
5. Explain the approved dosing guidelines and recommended dosage adjustments for the medications reviewed.
MEDICATION THERAPY MANAGEMENT: AN OVERVIEW OF CORE ELEMENTS
ACPE # 0043-9999-12-003-L01-P
REGINAL HARRIS, Pharm D
Texas A&M University Health Sciences Center
Dr. Harris is the founder and president of Infosource Communications, serving as the senior consultant pharmacist providing a variety of pharmacy consulting services to hospitals, long-term care facilities, and retail and independent pharmacies. He currently serves on the college of pharmacy faculty for Texas A&M University Health Sciences Center as well as the University of Colorado Health Sciences Center. Dr. Harris maintains an excellent grasp on the changing trends in the pharmacy profession by offering continuous quality improvement programs and other clinical services.
Objectives:
1. Define Value Added Services through a Medication Therapy Management Services (MTMS) program.
2. Discuss Centers for Medicare and Medicaid Services (CMS) MTMS programs under Medicare Part D.
3. Explain steps in developing an MTMS program according to CMS guidelines.
4. Review marketing, strategies and techniques for starting an MTMS program.
5. Outline concrete steps of implementing, documenting, and follow-up of an MTMS program.
6. List various methods of coding and billing from MTMS as allowed by CMS and Part D plans.
7. Review how the concepts of MTMS are used in a smaple patient case.
Advances in HIV Therapy, New Drug Update, Medication Therapy Management (MTM)
15
Swan & Dolphin Hotel Enjoy our seminars in the heart of Disney. Hotel located next to Epcot and the Boardwalk Hotel.
Dr. Terriff has provided clinical pharmacy services to Internal Medicine and Critical Care medical teams at Deaconess Medical Center over the past 12 years. She provides pharmaceutical care to HIV/AIDS patients in an outpatient clinic. Shefounded a post-graduate pharmacy residency in infectious disease. Dr. Terriff teaches a multitude of topics in required and elective infectious disease courses to pharmacy students .
MONDAY APRIL 23, 2012
INFECTIOUS DISEASES: AN UPDATE IN THE TREATMENT OF HIV, HEPATITIS and OPPORTUNISTIC INFECTIONS
ACPE # 0043-9999-11-029-L01-P
Objectives:
1. Recognize the etiology, modes of transmission and prevention of HIV infection.
2. State information about lab tests used to diagnose and monitor the course of HIV infection and progression to AIDS
3. Recognize the mechanism of action of commonly used antiretrovirals.
4. Identify the main antiretroviral side effects among drug classes
5. Given a patient case, recommend when and what to start for initial antiretroviral therapy, a regimen to reduce transmission from mother-to-baby, and vaccinations for preventable diseases.
6. Identify whether a patient is acutely or chronically infected with a hepatitis virus.
7. Select an appropriate pre-exposure therapy (i.e. Vaccination)
8. Select an appropriate post-exposure prophylaxis to hepatitis
9. Select an appropriate medication therapy for chronic suppression / treatment of hepatitis
10. Define primary and secondary prophylaxis to opportunistic infections.
11. Given a patient case (i.e. mucocutaneous candidiasis, PCP, toxo, MAC) recognize the infection when given symptoms and recommend prophylaxis and treatment regimen.
Dr. Long is a Bernhardt Professor pf Pharmacology and Toxicology in the faculty of Southwestern Oklahoma State University. He has worked as a pharmacist in the Public Health Services and in retail and hospital settings. His areas of expertise include pharmacognosy, pharmacology, and toxicology of natural products; veterinary pharmacology; toxicology of agrichemicals and pesticides; and substance misuse, abuse and addiction. Dr. Long has contributed chapters to Comprehensive Pharmacy Review and the Professional's Handbook of Complimentary and Alternative Medicines.
Objectives:
1. Review scientific and clinical data to assess the potential benefit and/or harm that alternative therapies present.
2. Assess the benefits and risks to a patient's health in recommending alternative therapies.
3. Demonstrate knowledge of the most commonly used herbal products.
Dr. Long is a Bernhardt Professor pf Pharmacology and Toxicology in the faculty of Southwestern Oklahoma State University. He has worked as a pharmacist in the Public Health Services and in retail and hospital settings. His areas of expertise include pharmacognosy, pharmacology, and toxicology of natural products; veterinary pharmacology; toxicology of agrichemicals and pesticides; and substance misuse, abuse and addiction. Dr. Long has contributed chapters to Comprehensive Pharmacy Review and the Professional's Handbook of Complimentary and Alternative Medicines.
Objectives:
1. Describe the differneces between disease state, behavioural / developmental / environmental, academic, and diathesis / stress theories of drug addiction.
2. Distinguish between the various levels of drug use.
3. Describe the goa;s of primary, secondary, and tertiary intervention.
4. Discuss the differences between supply, demand, and harm reduction appraoches to the "drug problem".
5. Understand the challenges recovering addicts face and describe means of helping the recovering addict.
6. Provide information on the legality of cannabis use by state.
7. Discuss the mechanism / pharmacodynamic effects of cannabis.
8. Counsel patients on potential side effects / toxicities of cannabis use.
9. Educate patients on potential benefit, harm, or ineffectiveness of cannabis for appropriate disease states.
Kimberly Burns is an Associate Professor at the LECOM School of Pharmacy, located in Erie, PA. Kim received her BS in Pharmacy from the University of Pittsburgh School of Pharmacy (1994, cum laude) and her Juris Doctor degree from Duquesne University Law School (2002, cum laude). She is both a licensed pharmacist and attorney in Pennsylvania. She has been a professor at LECOM for over 9 years, and her teaching responsibilities include pharmacy law and ethics, patient safety and medication related errors, pharmacy practice management, and various electives. Kim has consulted on various legal cases regarding pharmacy law issues. She has written a number of papers and commentaries, and has made presentations at the local, state, and national level on a variety of pharmacy law topics.
Objectives:
1. Identify significant federal legislation affecting pharmacy practice.
2. List specific mandates of federal law which requires pharmacist action and compliance in order to avoid violations.
3. Explain how laws provide patient benefits and positive outcomes.
4. Understand causes for medication errors.
5. Describe methods to prevent medication errors and reduce risk associated with those errors.
Herbal Products & Alternative Therapies, Substance Addiction, Medical Marijuana, Pharmacy Law & Medication Errors
Dr. Virgil Van Dusen is a professor of pharmaceutical sciences in the College of Pharmacy at Southwestern Oklahoma State University in Weatherford. He has authored numerous articles dealing with legal and management issues related to pharmacy practice and has a special interest in legal concerns for pharmacy education. Dr. Van Dusen is a nationally recognized consultant in pharmacy law.
Objectives:
1. Identify significant federal legislation affecting pharmacy practice.
2. List specific mandates of federal law which requires pharmacist action and compliance in order to avoid violations.
3. Explain how laws provide patient benefits and positive outcomes.
4. Understand causes for medication errors.
5. Describe methods to prevent medication errors and reduce risk associated with those errors.
Dr. Virgil Van Dusen is a professor of pharmaceutical sciences in the College of Pharmacy at Southwestern Oklahoma State University in Weatherford. He has authored numerous articles dealing with legal and management issues related to pharmacy practice and has a special interest in legal concerns for pharmacy education. Dr. Van Dusen is a nationally recognized consultant in pharmacy law.
